Luteal phase support in ovarian induction cycles using human chorionic gonadotropin or oral progestagens

Saudi Medical Journal

Volumn 24, Issue 1, 2003, Pages 34-36

  Zayed, Faheem F ^a,b   El Jallad, Mohammad F ^a   Al Chalabi, Haifa A ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b Al Hammadi Hospital   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; DYDROGESTERONE; GESTAGEN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG USE; FEMALE; FEMALE INFERTILITY; FREQUENCY ANALYSIS; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; JORDAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MULTICENTER STUDY; OVARY CYCLE; OVULATION INDUCTION; PREGNANCY; PROSPECTIVE STUDY; SAUDI ARABIA; SPONTANEOUS ABORTION; THEORY; TIME; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; CHORIONIC GONADOTROPIN; DYDROGESTERONE; FEMALE; HUMANS; INFERTILITY, FEMALE; INJECTIONS, INTRAMUSCULAR; LUTEAL PHASE; OVULATION INDUCTION; PREGNANCY;

EID: 0037226156     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Olsen JL, Rebar RW, Schreiber JR, Vaitukaitis JL. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin. Fertil Steril 1983; 39: 284-291
2. Nakamura Y, Yoshimura Y, Tanabe K, Lizuka R. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile women. Fertil Steril 1986; 46: 46-54.
3. DeCherney AH, Tarlatzis BC, Laufer N. Follicular development: Lessons learned from human in vitro fertilization. Am J Obstet Gynecol 1985; 153: 911-923.
4. Hutchinson-Williams KA, Lunenfeld B, Diamond MP. Human chorionic gonadotropin, estradiol and progesterone profiles in conception and nonconception cycles in an invitro fertilization program. Fertil Steril 1989; 3: 441-445.
5. Devroey P, Smitz J, Bourgain C, Van Stierteghem A.(1992). Only micronized progesterone is needed to substitute the luteal phase in stimulated cycles. Contracept Fertil Sex 1992; 20: 7-8.
6. Soliman S, Daya S, Collins J, Hughes E. The role of luteal phase support in infertility treatment: a meta-analysis of randomised trials. Fertil Steril 1994; 61: 1068-1076.
7. Blumenfeld Z, Nahhas F. Luteal dysfunction in ovulation induction: The role of repetitive human chorionic gonadotropin supplementation during the luteal phase. Fertil Steril 1988; 50: 403-407.
8. Messinis IE, Bergh T, Wide L. The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility. Fertil Steril 1988; 50: 31-35.
9. Yovich JL, McColm SC, Yovich JM, Mason PL. Early luteal serum progesterone concentrations are higher in pregnancy cycles. Fertil Steril 1985; 44: 185-189
10. Gidley-Baird AA, O'Neill C, Sinosich MJ, Porter RN, Pike IL, Saunders DM. Failure of implantation in human in vitro fertilization and embryo transfer patients: the effect of altered progesterone/oestrogen ratio in human and mice. Fertil Steril 1986; 45: 69-74.
11. Lejeune B, Camus D, Deschatcht J, Leory F. Difference in the luteal phase after failed or successful in vitro fertilization and embryo replacement. J In Vitro Fert Embryo Transf 1986; 3: 358-365.
12. Daya S. Efficacy of progesterone support in luteal phase following in-vitro fertilization and embryo transfer: metanalysis of clinical trials. Hum Reprod 1988; 3: 731-734.
13. Edwards RG, Steptoe PC, Purdy JM. Establishing full-term human pregnancies using cleaving embryos grown in vitro. Br J Obstet Gynaecol 1980; 87: 737-756.
14. Keenan, JA, Moghissi KS. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles. Obstet Gynecol 1992; 79: 983-987.